GlobeNewswire

Novozymes delivers resilient full-year results despite the COVID-19 pandemic and is confident about getting back to growth in 2021

Share

Novozymes delivered flat organic sales growth in the 2020 financial year and an EBIT margin of 26.1%. In 2021 the company expects
2-6% organic growth supported by innovation, stronger commercial presence, and gradual industry recovery. EBIT margin is expected at a solid 25-26%.

COPENHAGEN, Denmark – February 2, 2021. In the fourth quarter of the 2020 financial year, Novozymes’ organic sales growth was -3% with reported sales in DKK of -8%. Full-year organic sales growth was 0% with reported sales in DKK down by 3% and an EBIT margin of 26.1%. Full-year ROIC including goodwill was 18.9%.

“We deliver flat organic sales growth and an EBIT margin of 26% in a year unlike any other in recent history. Our advances through 2020 are a testament to the Novozymes purpose, culture, and well-diversified business model. I’m extremely proud of the work teams across the entire organization have done under these very difficult circumstances. We have managed to make progress and deliver resilient performance despite the pandemic,” says Ester Baiget, President & CEO and continues:

“Despite the prevailing uncertainties, I’m confident that we will get back to growth in 2021. Growth will be supported by a more streamlined organization, a stronger commercial presence, innovation, and a gradual recovery in the industries negatively impacted by the COVID-19 pandemic. Our global manufacturing sites are fully operational in terms of production and supply chain, and the company continues to fully meet demand.”

For the full year, organic growth rates by business area were 5% (Q4: 0%) in Household Care, 1% (Q4: -4%) in Food, Beverages & Human Health, -9% (Q4: -4%) in Bioenergy, -1% (Q4: -4%) in Grain & Tech Processing, and 1% (Q4: -6%) in Agriculture, Animal Health & Nutrition.

Household Care delivered solid organic sales growth driven by the rollout of the Freshness platform, strong market penetration in emerging markets, and changes to consumer behavior induced by COVID-19. Food, Beverages & Human Health organic sales were up slightly as food and human health grew while beverages declined due to COVID-19 effects.

Organic sales declined in Bioenergy and Grain & Tech Processing as COVID-19 impacted ethanol and textile production. In Agriculture, Animal Health & Nutrition, organic sales grew slightly supported by the rollout of Balancius™, stronger inoculant sales in BioAg as well as a one-off.

For the full year, organic growth rates by geography were 3% (Q4: -1%) in Europe, Middle East & Africa, -4% (Q4: -5) in North America, -1% (Q4: -3) in Asia Pacific, and 6% (Q4: -3) in Latin America.

2020-highlights
Novozymes launched 18 products across business areas in 2020 and made good progress on the commercialization of the innovation in key platforms such as Freshness and Balancius.
Among others, the company reached a key milestone with its first internal Human Health product launch; BioFresh® 4+. The Human Health business also advanced by two game-changing acquisitions.

In June, Novozymes acquired PrecisionBiotics Group to strengthen its Human Health business and advance its activities in the area of biological solutions for human oral and gut health. In December, Novozymes acquired US-based Microbiome Labs adding a strong position in the North American probiotics market and gaining access to the company’s network of health practitioners.

Financial guidance for 2021
Novozymes is guiding for 2-6% organic sales growth reflecting continued covid-19 related uncertainty but a gradual recovery in those markets that were negatively affected by the pandemic.

Sales in reported DKK are expected to be 1 percentage point less than the organic growth outlook of 2-6%.  Novozymes expects a reported EBIT margin in DKK of 25-26% including negative impact from currency and M&A-related effects of around 1 percentage point each.

Food, Beverages & Human Health and Grain & Tech Processing are expected to grow mid-single-digits while Bioenergy is expected to grow between mid-to-high single digits in 2021. The growth outlook for Household Care is low-single-digits following the strong performance in 2020. Agriculture, Animal Health & Nutrition is expected between flat to low-single-digit growth.

About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel, and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com

NASDAQ OMX: NZYM-B • 6,500 employees • DKK 14,5 billion turnover • 30+ industries • 700+ products

Media Relations
Lina Danstrup,
Head of Media Relations
Phone: +45 30 77 05 52
likr@novozymes.com
Investor Relations
Tobias Cornelius Björklund
Head of Investor Relations
Phone: +45 30 77 86 82
tobb@novozymes.com

Attachment


About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

CrossAmerica Partners LP Reports Fourth Quarter and Year-End 2020 Results1.3.2021 22:15:00 CETPress release

Allentown, March 01, 2021 (GLOBE NEWSWIRE) -- CrossAmerica Partners LP Reports Fourth Quarter and Year-End 2020 Results Reported Fourth Quarter 2020 Operating Income of $8.1 million and Net Income of $9.0 million compared to Operating Income of $9.4 million and Net Income of $4.3 million for the Fourth Quarter 2019Generated Fourth Quarter 2020 Adjusted EBITDA of $24.4 million and Distributable Cash Flow of $26.2 million compared to Fourth Quarter 2019 Adjusted EBITDA of $25.6 million and Distributable Cash Flow of $18.8 millionReported Fourth Quarter 2020 Gross Profit for the Wholesale Segment of $36.8 million compared to $32.7 million of Gross Profit for the Fourth Quarter 2019Reported Fourth Quarter 2020 Gross Profit for the Retail Segment of $19.5 million compared to $2.3 million of Gross Profit for the Fourth Quarter 2019Distributed 308.5 million wholesale fuel gallons during the Fourth Quarter 2020 at an average wholesale fuel margin per gallon of 7.8 cents Reported Full Year 2020

Historic Hyperloop Vehicle to be Unveiled to the Public at the Smithsonian FUTURES Exhibition this Fall1.3.2021 21:32:46 CETPress release

Vehicle made history in November 2020 carrying the world’s first hyperloop passengers Virgin Hyperloop joins the ranks of cutting-edge innovations debuted at Smithsonian WASHINGTON, March 01, 2021 (GLOBE NEWSWIRE) -- Just months after the world’s first hyperloop passenger testing, Virgin Hyperloop today announced that the passenger-carrying vehicle, dubbed “Pegasus,” will be making its public debut at the Smithsonian Arts + Industries Building in November 2021. Previously, the Building has showcased world-changing inventions like Edison’s lightbulb, the first telephones, and Apollo rockets. “Growing up, I spent family vacations at the Smithsonian National Air and Space Museum, seeing first-hand how engineers could change the world,” said Josh Giegel, CEO and Co-Founder of Virgin Hyperloop. “Having the vehicle the Virgin Hyperloop team created on display at the Smithsonian, inspiring the next generation of engineers to think big, is truly a dream come true.” The historic Arts + Industri

GOGL – Special General Meeting1.3.2021 21:00:00 CETPress release

1 March 2021 Golden Ocean Group Limited (NASDAQ and OSE: GOGL) (the "Company”) advises that a Special General Meeting of the Company will be held on 26 March 2021 to consider a proposal to increase the Company's authorized share capital. The record date for voting at the Special General Meeting is set to 3 March 2021. The notice, agenda and any associated material will be distributed prior to the meeting. The Board of Directors Golden Ocean Group Limited Hamilton, Bermuda This information is subject of the disclosure requirements pursuant to Euronext Oslo Rule Book II item 4.2.4.

PRESS RELEASE: BIGBEN - DESCRIPTION OF THE SHARE BUY BACK PROGRAMME1.3.2021 18:35:00 CETPress release

Press release Lesquin, 1st March 2021 17:45hrs Description of the share buy back programme authorised by the Combined general meeting of 30 July 2020 and implemented by the Board of directors of 1 March 2021 Bigben Interactive announces the implementation of its share buyback programme authorised by the General Meeting of Shareholders on 30 July 2020. In this respect, the Company has provided an investment services provider, CIC Market Solutions, with a mandate to acquire shares. 1.Legal framework Pursuant to the provisions of Articles L. 225-209 et seq. of the French Commercial Code, Articles 241-1 to 241-7 of the General Regulations of the Autorité des Marchés Financiers (the French Stock Exchange Authority) and EU Regulation No. 596/2014 of the European Parliament and of the European Council of 16 April 2014 on market abuse, the aim of this description is to present the purpose and terms of the Company's share buyback programme. 2. Date of the combined general meeting of shareholder

CONDITIONS FOR THE RIKSBANK´S PURCHASES OF COMMERCIAL PAPER1.3.2021 16:20:00 CETPress release

Bid procedure, 2021-03-03CertificateCommercial paper issued in SEK by non-financial companies with their registered office in Sweden and with a remaining maturity of up to six months on the Bid date. i.e. with the latest maturity date as of 2021-09-03 Delivery may not be made in commercial paper purchased by the Counterparty from the issuer less than one week prior to the date for announcing the Special terms, i.e. the purchase may not have been made after 2021-02-22 BidsCounterparties may make one bid per Credit rating class and maturity class. Bids are made to tel 08-696 69 70 and confirmed by e-mail to EOL@riksbank.se.Bid date2021-03-03Bid times09.00-09.30 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)SEK 4 billionHighest permitted bid volume (corresponding nominal amount)The total bid volume from one Counterparty for the two Credit rating classes may not exceed SEK 4 billion. No bid may contain Commercial paper in excess of SEK 250 million issued by the s

RAPALA VMC CORPORATION - NOTICE TO THE ANNUAL GENERAL MEETING1.3.2021 16:00:00 CETPress release

Rapala VMC Corporation Stock Exchange Release March 1, 2021 at 17:00 p.m. RAPALA VMC CORPORATION - NOTICE TO THE ANNUAL GENERAL MEETING Notice is given to the shareholders of Rapala VMC Corporation (“Rapala” or the “Company”) to the Annual General Meeting to be held on Thursday 25 March 2021 starting at 10:00 a.m. (EET) at the address Mäkelänkatu 91, 00610, Helsinki, Finland. The Company’s Board of Directors has resolved on exceptional meeting procedures based on the temporary legislative act to limit the spread of the Covid-19 pandemic (677/2020), which entered into force on 3 October 2020. In order to ensure the health and safety of the shareholders, employees and other stakeholders of the Company, the Annual General Meeting will be organized without shareholders’ and their proxy representatives’ presence at the Annual General Meeting venue. Shareholders can participate in the Annual General Meeting and use their shareholder rights in connection with the Annual General Meeting by vot

Nordic American Tankers Ltd (NYSE: NAT) – Comments on the market – Founder, Chairman & CEO is buying stock again1.3.2021 15:43:20 CETPress release

March 1, 2021 Dear Shareholders and Investors, We released our 2020 numbers last Friday, February 26, 2021. 2020 was a good year. We achieved excellent results for three quarters, whilst the fourth quarter was weak. At this time we clearly see a positive turn in the market for the NAT Suezmaxes. Last week we concluded a spot contract at about USD 20,000 a day and another spot contract at about USD 15,000 a day. A week ago the comparable number was about USD 4,000 a day. Operating costs are covered at USD 8000/day. I would also like to advise you that today I have bought 50,000 shares at USD 3.13. My son, Alexander Hansson and I are among the largest shareholders of NAT. Sincerely, Herbjorn Hansson Founder, Chairman & CEO Nordic American Tankers Ltd. www.nat.bm CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections fo